Myeloproliferative Disorders (MPD)
Also known as: Myeloproliferative Disorders / Myeloproliferative Disorder / Myeloproliferative Diseases / Myeloproliferative Disease / Myeloproliferative Syndromes / Myeloproliferative Syndrome / Chronic myeloproliferative disease / Myeloproliferative neoplasm / Myeloproliferative disorder NOS / Chronic myeloproliferative disease -RETIRED- / Myeloproliferative disorder (morphologic abnormality) / Disorder myeloproliferative / Myeloproliferative disorder (disorder) / Myeloproliferative disease (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00261 | Anagrelide | A platelet-reducing agent used to treat thrombocythemia, and its related complications, secondary to myeloproliferative neoplasms. |
| DB00619 | Imatinib | A tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors. |
| DB00034 | Interferon alfa-2a | A form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. |